Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Parkinson's Disease (PD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California Davis, Sacramento, California, United States
Study leads
William K Schmidt, PhD
Study Director
EicOsis Human Health Inc.
Lin Zhang, MD, PhD
Principal Investigator
UC Davis Health